Role of Bumetanide in Treatment of Autism

ConditionAutism

Trial statusRecruiting

Trial phasePhase 3

Trial typeInterventional

Biological sexAll

Age3-12

SponsorSherief Abd-Elsalam

About this trial

Role of bumetanide in Autism

Eligibility criteria

Qualifiers

All patients with ASD diagnosed by CARS rating Scale⩾30.

Age of patients range between (3-12) years.

Disqualifiers

Patients with ASD associated with neurological antecedents (including epilepsies and febrile seizures), hepatic, renal dysfunction or electrocardiogram abnormalities and syndromatic children(Rett).

Trial design

Treatments tested in this trial

Bumetanide
Placebo

Treatment groups

80 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Sherief Abd-Elsalam

Lead sponsor

Tanta University

Sponsor institution

Source ClinicalTrials.gov